Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a nurse via licensee and described the occurrence of headache in a 16-year-old female patient who received Influenza vaccine Quadrivalent. Co-suspect products included Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and Meningitis B vaccine. On 29th October 2015, the patient received Influenza vaccine Quadrivalent, the 2nd dose of Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and the 1st dose of Meningitis B vaccine. In 2015, less than a month after receiving Influenza vaccine Quadrivalent and Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced headache. In 2015, the outcome of the headache was recovered/resolved. The reporter considered the headache to be related to Influenza vaccine Quadrivalent and Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On Thursday, 29th October 2015, the patient received 1st dose of TRUMENBA and 2nd dose of Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine in her left arm. On the same day, the patient received Influenza vaccine Quadrivalent in her right arm. The patient then complained of experiencing a bad headache for two and half days and this was reported by patient''s mother at the office. The patient''s mother began some sort of medication at home for the patient''s headache but she did not say what the medication was. The sales representative of other manufacturer reported that he did not have any patient details including name, medical history and other details and added that the doctor''s office will be happy to share other information. The reporter mentioned that the doctor did not know but he suspect that the adverse event was related to the vaccines. The doctor also did not know if it was combination of the vaccines or a single vaccine and they were actually calling to find out that and the reporter told them to call Medical Affairs to find the information. The sales representative called back to confirm the reporter of the adverse event and nurse as confirmed as reporter who had same address and contact as of doctor and added that he did not have the email address of the doctor. Limited information was available to the sales representative. It was unknown if the reporter considered the headache to be related to TRUMENBA. This case has been linked to case US2015GSK172261, reported by the same reporter.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166